Search Results - "Parra‐López, Carlos A."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial by Bernal-Estévez, David A., Ortíz Barbosa, Mauren A., Ortíz-Montero, Paola, Cifuentes, Claudia, Sánchez, Ramiro, Parra-López, Carlos A.

    Published in Frontiers in immunology (20-08-2021)
    “…IntroductionAnimal studies and preclinical studies in cancer patients suggest that the induction of immunogenic cell death (ICD) by neoadjuvant chemotherapy…”
    Get full text
    Journal Article
  2. 2

    Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Colombia by Guerra, Julio, Mogollón, Daniel, González, Deccy, Sanchez, Ricardo, Rueda, Zulma Vanessa, Parra-López, Carlos A, Murcia, Martha Isabel

    Published in PloS one (25-01-2019)
    “…Active tuberculosis (TB) and latent tuberculosis infection (LTBI) are a public health threat in prisons around the world. The objectives of the study were to…”
    Get full text
    Journal Article
  3. 3

    An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses by Parra-López, Carlos A, Bernal-Estévez, David, Yin, Liusong, Vargas, Luis Eduardo, Pulido-Calixto, Carolina, Salazar, Luz Mary, Calvo-Calle, J Mauricio, Stern, Lawrence J

    Published in PloS one (01-07-2014)
    “…Malaria is transmitted by Plasmodium-infected anopheles mosquitoes. Widespread resistance of mosquitoes to insecticides and resistance of parasites to drugs…”
    Get full text
    Journal Article
  4. 4

    Usefulness of IL-21, IL-7, and IL-15 conditioned media for expansion of antigen-specific CD8+ T cells from healthy donor-PBMCs suitable for immunotherapy by Chamucero-Millares, Julián A., Bernal-Estévez, David A., Parra-López, Carlos A.

    Published in Cellular immunology (01-02-2021)
    “…•Peptide-pulsed PBMCs and moDCs drive strong expansion of Ag-specific CD8+ T cells.•IL-21, 7, 15 promote the expansion of CD8+ T cells with an early memory…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy by Bernal-Estnvez, David A, Garcia, Oscar, Sanchez, Ramiro, Parra-Lopez, Carlos A

    Published in BMC cancer (15-01-2018)
    “…Vaccination of mice with tumors treated with Doxorubicin promotes a T cell immunity that relies on dendritic cell (DC) activation and is responsible for tumor…”
    Get full text
    Journal Article
  7. 7

    Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9 by Parra, Miguel, Herrera, Daniel, Calvo-Calle, J. Mauricio, Stern, Lawrence J, Parra-López, Carlos A, Butcher, Eugene, Franco, Manuel, Angel, Juana

    Published in Virology (New York, N.Y.) (01-03-2014)
    “…Abstract Using a consensus epitope prediction approach, three rotavirus (RV) peptides that induce cytokine secretion by CD4 T cells from healthy volunteers…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors alpha 4 beta 7 and CCR9 by Parra, Miguel, Herrera, Daniel, Calvo-Calle, JMauricio, Stern, Lawrence J, Parra-Lopez, Carlos A, Butcher, Eugene, Franco, Manuel, Angel, Juana

    Published in Virology (New York, N.Y.) (01-03-2014)
    “…Using a consensus epitope prediction approach, three rotavirus (RV) peptides that induce cytokine secretion by CD4 T cells from healthy volunteers were…”
    Get full text
    Journal Article
  10. 10

    An immune surveillance model to monitor the response to neo-adjuvant chemotherapy treatment in breast cancer patients by Bernal-Estñvez, David A, García, Oscar A, Sanchez, Ramiro, Parra-López, Carlos A

    Published in Journal for immunotherapy of cancer (04-11-2015)
    “…BackgroundTumors treated with doxorubicin generates immunogenic cell death of tumor cells, favoring cross-presentation of tumor antigens by DCs to CD8 T cells…”
    Get full text
    Journal Article
  11. 11

    Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway by Parra-Lopez, CA, Lindner, R, Vidavsky, I, Gross, M, Unanue, ER

    Published in The Journal of immunology (1950) (15-03-1997)
    “…We compared the processing and presentation of the model Ag, hen-egg white lysozyme (HEL) expressed in C3.F6 APC as a fusion protein to three different acid…”
    Get full text
    Journal Article